User Acceptability of a Device-Based Opioid Overdose Intervention
NCT04530591 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 97
Last updated 2021-07-07
Summary
This pilot study evaluates the needs of opioid users for a device-based intervention for opioid overdoses. The results of this one-time short questionnaire will inform development of a novel naloxone delivery device.
Conditions
- Opioid Overdose
- Opioid-use Disorder
- Substance Use Disorders
Interventions
- OTHER
-
Survey
Participants will complete a survey about their opioid use history, its impact on their lives, their current strategies for preventing or reversing opioid overdoses, and their preferences for a device-based intervention.
- OTHER
-
Interview
Participants will participate in a semi-structured interview, during which they will provide feedback on non-functional, "looks-like" prototypes of a naloxone delivery device.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Jacob Brenner, MD/PhD · University of Pennsylvania
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-08-25
- Primary Completion
- 2020-09-15
- Completion
- 2020-09-15
Countries
- United States
Study Locations
More Related Trials
-
Effects of Buprenorphine and Naloxone in Opiate Addicts - 4
NCT00000355 ·Status: COMPLETED ·Phase: PHASE1
-
Piloting a Naloxone Intervention in Philadelphia
NCT03305497 ·Status: COMPLETED
-
Naloxone Auto-injection in Healthy Volunteers
NCT05099614 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5
NCT00000330 ·Status: WITHDRAWN ·Phase: PHASE2
-
Incentivizing Buprenorphine-Naloxone Initiation in Emergency Departments
NCT03821103 ·Status: COMPLETED ·Phase: NA
-
The Impact of Co-Dispensing Naloxone to Patients Prescribed Chronic Opioid Therapy
NCT03337100 ·Status: COMPLETED ·Phase: NA
-
Buprenorphine Combination Tablet Feasibility - 1
NCT00000298 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of a Computerized Opioid Overdose Prevention Program
NCT02040077 ·Status: COMPLETED ·Phase: NA
-
Overdose Risk Management and Naloxone
NCT03933345 ·Status: UNKNOWN
-
Assessing Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers
NCT00134875 ·Status: TERMINATED ·Phase: NA
-
A Usability Assessment of Naloxone by Community Members
NCT03309449 ·Status: COMPLETED ·Phase: NA
-
Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence
NCT00134888 ·Status: COMPLETED ·Phase: NA
-
Buprenorphine Induction for Fentanyl Dependent Opioid Users
NCT04794790 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Increasing Patient Knowledge of the Signs of Opioid Overdose and Naloxone in a Suburban Treatment Program
NCT02120612 ·Status: COMPLETED
-
Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence
NCT00134914 ·Status: COMPLETED ·Phase: NA
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2
NCT00000327 ·Status: WITHDRAWN ·Phase: PHASE2
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6
NCT00000331 ·Status: WITHDRAWN ·Phase: PHASE2
-
Electronic Intervention to Chronic Opioid Therapy
NCT04198961 ·Status: COMPLETED ·Phase: NA
-
Impact of Bridge™ Device to Treat Opioid Withdrawal Symptoms
NCT05924945 ·Status: TERMINATED ·Phase: NA
-
Increasing Naloxone Access for Persons Who Use Opioids
NCT04303000 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacodynamic Evaluation of Intranasal Nalmefene
NCT04828005 ·Status: COMPLETED ·Phase: PHASE1
-
Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9
NCT00000344 ·Status: COMPLETED ·Phase: PHASE2
-
Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder
NCT05053503 ·Status: COMPLETED ·Phase: NA
-
Evaluating an Intervention to Prevent Overdoses in Rural and Urban Counties
NCT05463341 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Nasal Naloxone for Narcotic Overdose
NCT01912573 ·Status: UNKNOWN ·Phase: PHASE4